GeneralTop StoryTop StoryLatest News
Malaria Vaccine Price Cut to Protect 1 Million More Children
Sentiment: NeutralHigh Priority
What Happened?
Bharat Biotech, Gavi, and UNICEF will reduce the RTS,S/AS01 malaria vaccine price by 40% to €5.50 per dose, saving $50 million for immunization programs from 2027 to 2029.
Key points
- The RTS,S/AS01 malaria vaccine price will drop to €5.50 per dose starting in early 2027.
- The price cut is expected to save $50 million for childhood immunization programs.
- The RTS,S/AS01 vaccine can reduce malaria cases by about 75% when given seasonally.
- Over 74 million doses of malaria vaccines have been delivered since their rollout in 2024.
- In 2024, an estimated 282 million malaria cases and 610,000 deaths were reported globally.
Key insights
- The price reduction may allow countries to allocate their immunization budgets more effectively.
- Increased access to the vaccine could significantly impact child health in malaria-endemic regions.
- The ongoing demand for malaria vaccines indicates a growing recognition of the disease's threat.
Why it matters
The price cut could enable countries to vaccinate more children against malaria, a major cause of childhood illness and death.
Entities
Bharat Biotech· CompanyGavi· OrganizationUNICEF· OrganizationRTS,S/AS01· ProductAfrica· Location
Source
India Today
